We serve Chemical Name:9,10,12,13-tetrabromostearic acid CAS:1794-89-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:9,10,12,13-tetrabromostearic acid
CAS.NO:1794-89-4
Synonyms:Tetrabrom-stearinsaeure;9,10,12,13-Tetrabromooctadecanoic Acid;9,10,12,13-tetrabromo-octadecanoic acid;9,10,12,13-Tetrabrom-octadecansaeure;9,10,12,13-Tetrabromostearic Acid;EINECS 217-266-0;9,10,12,13-Tetrabromstearinsaeure;9,10,12,13-Tetrabromostearic acid
Molecular Formula:C18H32Br4O2
Molecular Weight:600.06100
HS Code:2915900090
Physical and Chemical Properties:
Melting point:115ºC
Boiling point:565.8ºC at 760mmHg
Density:1.602g/cm3
Index of Refraction:1.541
PSA:37.30000
Exact Mass:595.91400
LogP:7.82610
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Tetrabrom-stearinsaeure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,9,10,12,13-Tetrabromostearic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,9,10,12,13-Tetrabromostearic acid Use and application,9,10,12,13-Tetrabromostearic Acid technical grade,usp/ep/jp grade.
Related News: Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 9,10,12,13-tetrabromostearic acid manufacturer Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037. 9,10,12,13-tetrabromostearic acid supplier At the same time, through years of imitation and advanced technology learning, more and more domestic companies have participated in the field of highly original and characteristic APIs. 9,10,12,13-tetrabromostearic acid vendor Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. 9,10,12,13-tetrabromostearic acid factory Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.
